Benzinga | May 13, 2021 05:30PM EDT

Processa Pharmaceuticals Q1 EPS $(0.14) Misses $(0.10) Estimate

Processa Pharmaceuticals (NASDAQ:PCSA) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.10) by 40 percent.